top of page

August 2019 // News

  • andreachicca797
  • Aug 1, 2019
  • 1 min read

Updated: Dec 30, 2025



Synendos receives a co-fund by the European Union as part of the SME Instrument phase 1 (Horizon2020) to contribute to the translation of our preclinical programme into clinical development.



Recent Posts

See All
September 2025 // News

Dr. Andrea Chicca, CEO, shares the highly promising results from Synendos Phase 1 Trials

 
 
October 2024 // News

Synendos Secures Innosuisse Funding to Advance Clinical Development of SYT-510

 
 
July 2024 // News

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch

 
 
bottom of page